Improve Medical Instruments Co., Ltd. (300030) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Improve Medical Instruments Co., Ltd.

Why is Improve Medical Instruments Co., Ltd. ?

With a growth in Operating Profit of 404.01%, the company declared Very Positive results in Sep 25

OPERATING CASH FLOW(Y) Highest at CNY 135.4 MM
ROCE(HY) Highest at -7.83%
DEBT-EQUITY RATIO (HY) Lowest at 6.27 %

With ROE of -7.27%, it has a risky valuation with a 3.78 Price to Book Value

Over the past year, while the stock has generated a return of 36.51%, its profits have risen by 39.4%

Market Beating Performance

The stock has generated a return of 36.51% in the last 1 year, much higher than market (China Shanghai Composite) returns of 24.70%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Improve Medical Instruments Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Improve Medical Instruments Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Improve Medical Instruments Co., Ltd.

39.19%

2.73

43.22%

China Shanghai Composite

24.7%

1.91

12.95%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-8.20%

EBIT Growth (5y)

-185.09%

EBIT to Interest (avg)

-1.98

Debt to EBITDA (avg)

2.96

Net Debt to Equity (avg)

0.15

Sales to Capital Employed (avg)

0.59

Tax Ratio

0.70%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

1.84%

ROE (avg)

3.41%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.78

EV to EBIT

-40.69

EV to EBITDA

-83.68

EV to Capital Employed

3.78

EV to Sales

4.58

PEG Ratio

Dividend Yield

ROCE (Latest)

-9.28%

ROE (Latest)

-7.27%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

27What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 135.4 MM

ROCE(HY)

Highest at -7.83%

DEBT-EQUITY RATIO (HY)

Lowest at 6.27 %

RAW MATERIAL COST(Y)

Fallen by -25.66% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 3.58 times

PRE-TAX PROFIT(Q)

Highest at CNY 9.64 MM

NET PROFIT(Q)

Highest at CNY 10.92 MM

EPS(Q)

Highest at CNY 0.03

-9What is not working for the Company

CASH AND EQV(HY)

Lowest at CNY 305.63 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.65 times

NET SALES(Q)

At CNY 118.27 MM has Fallen at -8.87%

Here's what is working for Improve Medical Instruments Co., Ltd.

Operating Cash Flow

Highest at CNY 135.4 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit

At CNY 9.64 MM has Grown at 165.42%

over average net sales of the previous four periods of CNY -14.74 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 10.92 MM has Grown at 202.91%

over average net sales of the previous four periods of CNY -10.61 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Debt-Equity Ratio

Lowest at 6.27 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Pre-Tax Profit

Highest at CNY 9.64 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 10.92 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.03

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio

Highest at 3.58 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -25.66% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Improve Medical Instruments Co., Ltd.

Net Sales

At CNY 118.27 MM has Fallen at -8.87%

over average net sales of the previous four periods of CNY 129.78 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Cash and Eqv

Lowest at CNY 305.63 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 2.65 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio